Telomir Pharmaceuticals . Common Stock Stock Forecast

Sell candidate since Aug 04, 2026 Gain 2.61%

The Telomir Pharmaceuticals, Inc. Common stock price gained 2.61% on the last trading day (Wednesday, 5th Aug 2026), rising from $1.15 to $1.18. During the last trading day the stock fluctuated 4.88% from a day low at $1.13 to a day high of $1.19. The price has risen in 6 of the last 10 days and is up by 11.32% over the past 2 weeks. Volume fell on the last day by -2 thousand shares and in total, 75 thousand shares were bought and sold for approximately $88.07 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.24 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -9.38% during the next 3 months and, with a 90% probability hold a price between $0.81 and $1.13 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

TELO Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Telomir Pharmaceuticals, Inc. Common stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.20 and $1.22. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, July 30, 2026, and so far it has fallen -5.60%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Telomir Pharmaceuticals, Inc. Common stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.11 and $1.08. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Telomir Pharmaceuticals, Inc. Common finds support just below today's level at $1.11. If this is broken, then the next support from accumulated volume will be at $1.08 and $0.92.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0551 between high and low, or 4.88%. For the last week the stock has had daily average volatility of 5.31%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TELO) For The Upcoming Trading Day Of Thursday 6th

For the upcoming trading day on Thursday, 6th we expect Telomir Pharmaceuticals, Inc. Common Stock to open at $1.17, and during the day (based on 14 day Average True Range), to move between $1.14 and $1.22, which gives a possible trading interval of +/-$0.0872 (+/-7.67%) up or down from last closing price. If Telomir Pharmaceuticals, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 7.67% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.11 (5.93%) than the resistance at $1.25 (5.93%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Telomir Pharmaceuticals, Inc. Common Stock stock A Buy?

Telomir Pharmaceuticals, Inc. Common holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.506 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 6, 2026 - $1.17 ( 1.27%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk